These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9874584)

  • 1. New biological markers may accurately predict prognosis in head and neck cancer patients.
    Oncology (Williston Park); 1998 Oct; 12(10):1537. PubMed ID: 9874584
    [No Abstract]   [Full Text] [Related]  

  • 2. A new prognostic indicator for head and neck cancer--p53 serum antibodies?
    Gottschlich S; Folz BJ; Goeroegh T; Lippert BM; Maass JD; Werner JA
    Anticancer Res; 1999; 19(4A):2703-5. PubMed ID: 10470224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can molecular markers predict local, regional and distant metastasis in head and neck cancer?
    Haffty BG
    Nat Clin Pract Oncol; 2005 Mar; 2(3):132-3. PubMed ID: 16264904
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular markers of head and neck cancer].
    Temam S; Janot F
    Rev Prat; 2006 Oct; 56(15):1658-61. PubMed ID: 17137250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent changes in the epidemiology of head and neck cancer.
    Curado MP; Hashibe M
    Curr Opin Oncol; 2009 May; 21(3):194-200. PubMed ID: 19363341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New molecular diagnostic methods in head and neck cancer.
    Rodrigo JP; Ferlito A; Suárez C; Shaha AR; Silver CE; Devaney KO; Bradley PJ; Bocker JM; McLaren KM; Grénman R; Rinaldo A
    Head Neck; 2005 Nov; 27(11):995-1003. PubMed ID: 16200629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple cytokine and growth factor serum biomarkers predict therapeutic response and survival in advanced-stage head and neck cancer patients.
    Bigbee WL; Grandis JR; Siegfried JM
    Clin Cancer Res; 2007 Jun; 13(11):3107-8. PubMed ID: 17545511
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers.
    Ralhan R; Masui O; Desouza LV; Matta A; Macha M; Siu KW
    Proteomics; 2011 Jun; 11(12):2363-76. PubMed ID: 21598386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
    Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
    Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular predictors in head and neck tumours].
    Smilek P
    Klin Onkol; 2010; 23(4):218-23. PubMed ID: 20806819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor markers used in the diagnosis, monitoring, treatment, and prognosis head and neck cancer].
    Kopczyński P; Flieger R
    Pol Merkur Lekarski; 2013 Jul; 35(205):37-8. PubMed ID: 23984603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of the use of tests for human papilloma virus and epidermal growth factor receptor for squamous cell carcinoma of the head and neck in UK head and neck multidisciplinary teams.
    Ahmed A; Cascarini L; Sandison A; Clarke P
    Br J Oral Maxillofac Surg; 2012 Mar; 50(2):119-21. PubMed ID: 21450378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor markers of head and neck carcinoma.
    Eibling DE; Wagner RL; Johnson JT
    Immunol Ser; 1990; 53():357-83. PubMed ID: 2100567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of molecular markers in the management of head and neck cancers.
    Ferreira MB; De Souza JA; Cohen EE
    Curr Opin Oncol; 2011 May; 23(3):259-64. PubMed ID: 21358329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in head and neck oncology: a critical appraisal for use in clinical practice.
    Chiesa F; Tradati N; Mauri S; Calabrese L; Grigolato R; Giugliano G; Zurrida S; Chiesa E; Squadrelli M; Viale G; Maiorano E
    Anticancer Res; 1998; 18(6B):4769-76. PubMed ID: 9891555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor.
    Bongers V; Snow GB; de Vries N; Cattan AR; Hall AG; van der Waal I; Braakhuis BJ
    Lab Invest; 1995 Oct; 73(4):503-10. PubMed ID: 7474922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
    Linkov F; Lisovich A; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Nolen B; Winans M; Bigbee W; Siegfried J; Lokshin A; Ferris RL
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is gene expression profiling of head and neck cancers ready for the clinic?
    Ziober AF; D'Alessandro L; Ziober BL
    Biomark Med; 2010 Aug; 4(4):571-80. PubMed ID: 20701444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of new serum tumor markers in head and neck squamous cell carcinoma.
    Marcos CA; Martínez DA; de Los Toyos JR; Domínguez Iglesias F; Hermsen M; Guervós MA; Pendás JL
    Otolaryngol Head Neck Surg; 2009 Mar; 140(3):375-80. PubMed ID: 19248946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of molecular markers and gene profiling in head and neck cancers.
    Gold KA; Kim ES
    Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.